Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation
Public ClinicalTrials.gov record NCT03729830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To obtain data for the Rhythmia™ Mapping System in conjunction with Boston Scientific Open-Irrigated (OI) Catheters for ablation of Paroxysmal Atrial Fibrillation (PAF) according to current international and local guidelines. Primary objective: To assess acute and long-term outcomes for the Rhythmia Mapping System in conjunction with Boston Scientific Open-Irrigated Ablation Catheters to treat de novo Paroxysmal Atrial Fibrillation. De Novo PAF is defined as subjects undergoing first ablation procedure for PAF with no prior left atrial ablation (RF, Cryo, Surgical).
Study identification
- NCT ID
- NCT03729830
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 415 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 3, 2019
- Primary completion
- May 2, 2024
- Completion
- May 2, 2024
- Last update posted
- Jan 20, 2026
2019 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Torrance Memorial Medical Center | Torrance | California | 90505 | — |
| Broward General Medical Center | Miami | Florida | 33136 | — |
| AdventHealth Orlando | Orlando | Florida | 32803 | — |
| St. Lukes Idaho Cardiology Associates | Boise | Idaho | 83712 | — |
| University of Chicago Hospital | Chicago | Illinois | 60637 | — |
| St. John's Hospital | Springfield | Illinois | 62769 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Nebraska Heart Institute | Lincoln | Nebraska | 68526 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756-1000 | — |
| Catholic Medical Center | Manchester | New Hampshire | 03102 | — |
| Kaleida Health | Buffalo | New York | 14213 | — |
| Bethesda North Hospital | Cincinnati | Ohio | 45220 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Lehigh Valley Hospital | Allentown | Pennsylvania | 18103 | — |
| HeartPlace Mid-Cities EP | Bedford | Texas | 76021 | — |
| Orion Medical | Pasadena | Texas | 77505 | — |
| Christus Trinity Mother Frances Health System | Tyler | Texas | 75701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03729830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03729830 live on ClinicalTrials.gov.